RecruitingPhase 1Phase 2NCT03331302

Hyper Polarized Xenon-129 MRI vs Xenon-133 Scintigraphy


Sponsor

University of Virginia

Enrollment

30 participants

Start Date

Sep 1, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

Hyper polarized Xenon-129 MRI will be directly compared to a radioactive Xe-133 scintigraphy to detect defects in lung ventilation from airflow limitation. This study is conducted as a pilot study with intention to conduct a larger clinical trial.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of lung imaging in COPD (chronic obstructive pulmonary disease) patients: a newer MRI technique using inhaled xenon-129 gas versus a traditional nuclear medicine scan using xenon-133, to see which better shows how air moves through the lungs. **You may be eligible if...** - You have a confirmed diagnosis of COPD - You are at your normal, stable health baseline on the day of imaging (not during a flare-up) - You are a current or former smoker with at least a 10 pack-year smoking history - Your COPD severity has been classified according to standard criteria (GOLD classification) **You may NOT be eligible if...** - You have a diagnosis of asthma - You require continuous oxygen at home - Your blood oxygen level is too low - You are currently experiencing a COPD flare-up Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHyperpolarized Xenon-129 MRI (Experimental)

MRI ventilation scan of the lung with inhaled contrast agent (hyperpolarized Xenon-129)

DRUGRadioactive Xenon-133 scintigraphy (Active Comparator)

Radioactive ventilation scintigraphy of the lung with inhaled radioactive contrast agent (Xenon-133)


Locations(1)

University of Virginia Health System

Charlottesville, Virginia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03331302


Related Trials